Since 2002, BioCrossroads has worked to catalyze innovation and collaboration within Indiana’s life sciences sector. The sector has grown at a remarkable pace and has generated billions of dollars in revenue for the state with $79 billion in economic impact in 2021. BioCrossroads plays a critical role by convening academic, philanthropic, and cross-sector employer partners, enhancing research development, and working to attract life sciences businesses, innovation, and talent to Indiana.  

This unique collaborative approach has proven to be successful in times of need. At the onset of the COVID-19 pandemic, BioCrossroads played a key role convening Indiana’s life science and healthcare partners troubleshoot COVID testing, vaccine development and deployment, and other needs for Indiana residents.  

The Richard M. Fairbanks Foundation has awarded $11.5 million to BioCrossroads since 2003 to advance the economic vitality of Indianapolis. 

Additional Posts

Our Commitment to Improving Student Learning Outcomes in Indianapolis

Claire Fiddian-Green is the President & CEO of the Richard M. Fairbanks Foundation. A well-educated population is critical to the vitality of Indianapolis and the continued competitiveness of our state. Unfortunately, too many students graduate from high school unprepared for college or careers. For example, according to the latest report from Indiana’s Commission for Higher […]

How Can We Effectively Engage and Treat Pregnant and Parenting Women with Opioid Use Disorder?

Alex Cohen is the Director of Learning and Evaluation for the Richard M. Fairbanks Foundation. The opioid epidemic continues to plague Indianapolis and the rest of the state. With the rise in opioid misuse, there has been a parallel surge in pregnant women with opioid use disorder. Infants born to opioid-dependent mothers are at a […]